Biologics CDMO | Biologics Contract Manufacturing Organization | Kemwe...
Kemwell Biopharma. Kemwell Biopharma provides customized process, product development & manufacturing solutions to biopharmaceutical...
Read Kemwellbiopharma.com news digest here: view the latest Kemwell Biopharma articles and content updates right away or get to their most visited pages. Kemwellbiopharma.com is not yet rated by Alexa. It seems that Kemwell Biopharma content is notably popular in India, as 91.5% of all users (13K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Kemwellbiopharma.com and thus you can safely use it. Kemwellbiopharma.com is hosted with CloudFlare, Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
489
Visitors daily -
489
Pageviews daily -
4
Google PR -
N/A
Alexa rank
Best pages on Kemwellbiopharma.com
-
Japan and USA In 2006, Kemwell acquired Pfizer’s facility in Uppsala, Sweden, retaining all manufacturing contracts and 200 people on site. This facility has over 50 years of experience in supplying p...
-
Biologics CDMO | Biologics Contract Manufacturing Organization | Kemwell
Kemwell Biopharma provides customized process, product development & manufacturing solutions to biopharmaceutical organizations worldwide
-
Sanjay has a Masters degree in Biochemical Engineering and Biotechnology. He has over 17 years of experience in biopharmaceutical process development, biopharmaceutical manufacturing and design & ex...
Kemwellbiopharma.com news digest
-
3 months
Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspecti...
Business Wire release
Milestone expands India’s role in global biologics manufacturing; collaboration with Cipla underscores commitment to quality and reliability
Bengaluru, India – October 28, 2025 – Kemwell Biopharma Pvt Ltd (“Kemwell”), a leading global biologics Contract Development and Manufacturing Organization (CDMO), announced today that its drug-product manufacturing facility in Bengaluru has successfully... -
8 months
Breaking Barriers: How Kemwell’s Mitigation Strategy Overcomes Viscosity-Induced...
Introduction:
Recent advances in biologics development are primarily focussed on development of high titre producing cell lines to substantiate the requirement of high dosage mAbs which may be as high as 600-700 mg drug per dose. This also brings in the requirement... -
10 months
Kemwell’s Expertise in Size Exclusion Chromatography for Isoform Separation of a...
Introduction:
Size variants determination is a critical quality attribute for a therapeutic recombinant antibody, since they can impact the drug product safety, potency, and efficacy. Size exclusion chromatography is the most frequently employed technique for estimation... -
10 months
Kemwell’s Approach to Considerations for Selecting Hydrolysates in Cell Culture ...
Introduction:
Hydrolysates have been used in cell culture media for cell growth and productivity enhancement. To finalize hydrolysate supplementation strategy, a comprehensive understanding of their impact on growth, productivity and product quality is required. This...
Domain history
| Web host: | CloudFlare, Inc. |
| Registrar: | GoDaddy.com, LLC |
| Registrant: | Registration Private (Domains By Proxy, LLC) |
| Updated: | August 21, 2024 |
| Expires: | August 23, 2027 |
| Created: | August 23, 2007 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A
